(Q40565480)

English

The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Possible contribution to tumor counterattack

scientific article published on May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Possible contribution to tumor counterattack (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

María José Martínez-Lorenzo

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Alberto Anel

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

María A Alava

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Andrés Piñeiro

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Javier Naval

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Pilar Lasierra

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Luis Larrad

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

295

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

315-329

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

The Fas death factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Cytotoxic T lymphocytes: all roads lead to death

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Decreased tumor surveillance in perforin-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Fas and Fas ligand interactions suppress melanoma lung metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Functional Consequences of APO-1/Fas (CD95) Antigen Expression by Normal and Neoplastic Hematopoietic Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Expression of CD95 ligand in melanocytic lesions as a diagnostic marker

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Cutting Edge: The Tumor Counterattack Hypothesis Revisited: Colon Cancer Cells Do Not Induce T Cell Apoptosis Via the Fas (CD95, APO-1) Pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Downregulation of Fas ligand by shedding

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Influence of alpha-melanocyte-stimulating hormone and ultraviolet radiation on the transfer of melanosomes to keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

B lymphocytes secrete antigen-presenting vesicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

The melanosome: membrane dynamics in black and white

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Signal transduction. FasL binds preassembled Fas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Malignant effusions and immunogenic tumour-derived exosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

The membrane-bound but not the soluble form of human Fas ligand is responsible for its inflammatory activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Regulation of the proinflammatory effects of Fas ligand (CD95L).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Is cancer dangerous to the immune system?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2003.12.024

7 January 2021

Identifiers

10.1016/J.YEXCR.2003.12.024

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40565480&oldid=1900603796"